Brief: Resonance Health Expects FY26 Underlying EBITDA A$2.6 Mln
May 5 (Reuters) - Resonance Health Ltd RHT.AX: EXPECTS FY26 UNDERLYING EBITDA OF A$2.6 MILLION, UP 30% FROM PRIOR GUIDANCE UPDATES FY26 REVENUE GUIDANCE TO A$16.0 MILLION FROM A$17.0 MILLION Further company coverage: RHT.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Resonance Health
See all newsBrief: Resonance Health Halts Trading In Resonance Health Securities Pending Announcement
Australia's Resonance Health gains on IAG agreement
Brief: Resonance Health Enters Global Strategic Alliance & MSA With Image Analysis Group
Brief: Resonance Health Posts Profit Attributable Of A$1.5 Million
Brief: Resonance Health Says It Expects FY27 Normalised EBITDA Of AUD 2.6 To 3.6 Million